Equity Components [Axis] Temporary Equity [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Long-Lived Tangible Asset [Axis] Land [Member] Building [Member] Antidilutive Securities [Axis] Stock Options [Member] Warrant [Member] Restricted Stock Units (RSUs) [Member] Product and Service [Axis] Consulting Service [Member] Sale of Stock [Axis] Private Placement [Member] Award Type [Axis] Series B Round [Member] IPO [Member] Over-Allotment Option [Member] July 2024 Firm Commitment Public Offering [Member] July 2024 Follow On Overallotment Warrants [Member] July 2024 Follow on Overallotment Warrant [Member] Title and Position [Axis] Lead Managing Underwriter [Member] October 2024 Follow On Offering [Member] October 2024 Follow On Over Allotment Option [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Purchase Agreement [Member] May 2025 Private Placement [Member] May 2025 Placement Agency Agreement [Member] Two Consultants [Member] Plan Name [Axis] 2025 Equity Incentive Plan [Member] 2023 Stock Option Plan [Member] Common Stock One [Member] Common Stock Two [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Share-Based Payment Arrangement, Option [Member] Award Date [Axis] One Third Grant Date Anniversary [Member] Grant Date Anniversary [Member] Six Month Grant Date Anniversary [Member] 2025 Equity Plan [Member] Land, Buildings and Improvements [Member] Legal Entity [Axis] Nuclear Technology Headquaters [Member] KRONOSMMR Microreactor Energy System [Member] Asset Acquisition [Axis] ALIP Technology [Member] Dr Maidana [Member] Investment, Name [Axis] LIS Technologies Inc [Member] Business Combination [Axis] Canadian Consents [Member] Income Tax Jurisdiction [Axis] State and Local Jurisdiction [Member] Domestic Tax Jurisdiction [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Underwriter Warrants [Member] Warrant One [Member] Warrant Two [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Accounts receivable, net Prepaid expenses Deposits, current Total current assets Deferred offering costs Deposits, non-current Property, plant and equipment, net Right-of-use assets Long-term investments, related party In-process research and development Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable and accrued liabilities Due to related parties Lease liabilities, current Contingent consideration Total current liabilities Lease liabilities, non-current Total liabilities Stockholders’ equity Preferred stock, $0.0001 par value; 25,000,000 authorized as of September 30, 2025 and September 30, 2024; none issued and outstanding as of September 30, 2025 and September 30, 2024 Common stock, $0.0001 par value; 275,000,000 authorized as of September 30, 2025 and September 30, 2024; 41,738,358 and 30,715,663 shares issued and outstanding as of September 30, 2025 and September 30, 2024, respectively Additional paid-in capital Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Operating expenses General and administrative Research and development Change in fair value of contingent consideration Loss from operations Other income Net loss Net loss per share of common stock: Basic Diluted Weighted-average shares of common stock outstanding: Basic Diluted Statement [Table] Statement [Line Items] Balance Mezzanine equity balance, amount Balance, shares Mezzanine equity balance, shares Common stock issuances Common stock issuances, shares Offering costs Exercise of warrants Exercise of warrants, shares Exercise of stock options Exercise of stock options, shares Equity-based compensation Net loss Mezzanine equity conversion Mezzanine equity conversion, shares Mezzanine equity conversion, value Mezzanine equity conversion, shares R&D acquisition common stock issuances R&D acquisition - common stock issuances, shares Equity-based compensation, shares Mezzanine equity balance, amount Balance Mezzanine equity balance, shares Balance, shares Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Adjustments to reconcile net loss to net cash used in operating activities: Equity-based compensation Amortization of right-of-use assets Depreciation R&D acquisition paid-in equity Changes in fair value of contingent liability Change in assets and liabilities: Prepaid expenses Deposits Accounts receivable Accounts payable and accrued liabilities Due to related parties Lease liabilities Contingent liability Net cash used in operating activities INVESTING ACTIVITIES In-process research and development Increase in long-term investments Additions to property, plant and equipment Net cash used in investing activities FINANCING ACTIVITIES Proceeds from common stock issuances Offering costs Proceeds from exercise of warrants Proceeds from exercise of stock options Payment of deferred offering costs Net cash provided by financing activities Net increase in cash Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Non-Cash Supplemental Disclosures Inception of Right-of-Use Asset / Lease Liability Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available [custom:NoInsiderTradingFlag] Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND OPERATIONS AND BASIS OF PRESENTATION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Other Income and Expenses [Abstract] OTHER INCOME Equity [Abstract] EQUITY Property, Plant and Equipment [Abstract] PROPERTY, PLANT AND EQUIPMENT Right-of-use Assets And Lease Liabilities RIGHT-OF-USE ASSETS AND LEASE LIABILITIES Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] ACQUISITION OF ALIP TECHNOLOGY Investments, All Other Investments [Abstract] LONG-TERM INVESTMENTS, RELATED PARTY Usnc Asset Acquisition USNC ASSET ACQUISITION Income Tax Disclosure [Abstract] INCOME TAXES Subsequent Events [Abstract] SUBSEQUENT EVENTS Principles of Consolidation Cash Equivalents Use of Estimates Fair Value Measurement Concentration of Credit Risk Accounts Receivable Prepaid Expenses Property, Plant and Equipment In-process Research and Development Depreciation Leases Warrant Instruments Investments in Equity – Related Party Mezzanine Equity Equity-Based Compensation Research and Development Advertising Costs Legal Contingencies Income Taxes Net Loss per Share Operating Segments Recent Accounting Pronouncements SCHEDULE OF STRAIGHT LINE METHOD BASED ON ESTIMATED USEFUL LIVES SCHEDULE OF SHARES EXCLUDED FROM DILUTED PER SHARE AMOUNT SCHEDULE OF CUMULATIVE OPTION ACTIVITY SCHEDULE OF CUMULATIVE WARRANT ACTIVITY SCHEDULE OF RESTRICTED STOCK UNIT ACTIVITY SCHEDULE OF PROPERTY , PLANT AND EQUIPMENT SCHEDULE OF RIGHT OF USE ASSET AND LEASE LIABILITIES SCHEDULE OF BALANCE SHEET INFORMATION SCHEDULE OF LEASE EXPENSE SCHEDULE OF OTHER INFORMATION RELATED TO LEASES SCHEDULE OF EXPECTED ANNUAL MINIMUM LEASE PAYMENTS SCHEDULE OF ALIP ACQUISITION SCHEDULE OF ALLOCATION OF CONSIDERATION SCHEDULE OF RECONCILIATION OF EFFECTIVE TAX RATE TO STATUTORY RATES SCHEDULE OF DEFERRED TAX ASSETS (LIABILITIES) Consultation services Working capital Accumulated deficit Net loss Net cash used in operating activities Exercises of warrants Exercises of stock options Net proceeds sale of equity Proceeds from issuance of private placement Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Property plant and equipment useful life Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total shares excluded Investments in equity Impairment on investments in equity Advertising costs OtherIncomeTable [Table] OtherIncomeLineItem [Line Items] Interest income Cash held at a financial institution Interest earned from lease agreement Non-refundable down payment Number of shares, outstanding, beginning Weighted average exercise price per share, outstanding, beginning Weighted average contractual term, outstanding Aggregate intrinsic value, outstanding, beginning Number of shares, granted Weighted average exercise price per share, granted Weighted average contractual term, granted Aggregate intrinsic value, granted Number of shares, exercised Weighted average exercise price per share, exercised Aggregate intrinsic value, exercised Number of shares, forfeited Weighted average exercise price per share, forfeited Aggregate intrinsic value, forfeited Number of shares, outstanding, ending Weighted average exercise price per share, outstanding, ending Aggregate intrinsic value, outstanding, ending Number of shares, outstanding , Exercisable at the end of period Weighted average exercise price per share, Exercisable at the end of period Weighted average contractual term, Exercisable at the end of period Aggregate intrinsic value, Exercisable at the end of period Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of warrant shares, outstanding, beginning Weighted average exercise price per share, outstanding, beginning Number of shares warrants issued Weighted average exercise price per share, issued Weighted average contractual term (in years), outstanding, warrant issued Number of shares warrants exercised Weighted average exercise price per share, exercised Weighted average contractual term (in years), outstanding Number of warrant shares, outstanding, ending Weighted average exercise price per share, outstanding, ending Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of shares, outstanding, beginning Weighted- average grant date fair value per share, outstanding beginning Aggregate intrinsic value, outstanding, beginning Number of shares, granted Weighted- average grant date fair value per share, granted Aggregate intrinsic value, granted Number of shares, outstanding, ending Weighted- average grant date fair value per share, outstanding ending Aggregate intrinsic value, outstanding, Ending Number of shares sale Share price Gross proceeds Issuance of shares Price per share Proceeds from issuance initial public offering Net proceeds Number of shares of warrants Price per share Additional paid in capital issuance costs Warrants to purchase shares Warrant issued Market price per share Gross proceeds from issuance of common stock Net proceeds from issuance of common stock Purchase of common stock Stock issuance costs Warrants exercised Warrant expiry Warrants and Rights Outstanding, Term Cash fee percentage Non accountable expense allowance percentage Legal expenses Temporary equity, shares issued Temporary equity, redemption price per share Temporary equity, carrying amount, attributable to parent Number of shares issued for services Number of shares issued, value Common stock available for issuance Share based compensation description Stock options Exercise price Expiry date Stock options, granted Expected life of options Estimated volatility Risk free interest rate Dividend rate Fair value of stock options issued, per share Stock-based compensation for stock options expected to vest Stock compensation expense weighted average period Value of stock options Stock compensation expense yet to be recognized Restricted stock units, granted Restricted stock units, fair value Restricted stock units, one-third vested Restricted stock units, percent RSU unrecognized compensation RSU weighted-average period Beginning of year Additions – land Additions – building Additions – leasehold improvements Additions – construction in progress End of year Accumulated depreciation Beginning of year Depreciation of building Depreciation of leasehold improvements End of year Total property, plant and equipment, net Area of land Money spend on acquisition of land Schedule Of Right Of Use Asset And Lease Liabilities Right-of-use assets Beginning of year Additions Amortization End of year Schedule Of Balance Sheet Information Operating right-of-use assets Operating lease liabilities, current Operating lease liabilities, long term Operating lease cost Operating cash outflows from operating leases Weighted-average discount rate - operating lease Weighted-average remaining lease term - operating lease (in years) 2026 2027 2028 2029 Thereafter Total future minimum lease payments, undiscounted Less: Imputed interest for leases in excess of one year Present value of future minimum lease payments Less: Current portion of lease liabilities Total lease liabilities, less current portion Asset Acquisition [Table] Asset Acquisition [Line Items] Total purchase price Cash (paid on closing) Common shares (issued on closing) Contingent cash Contingent common shares (fair value at closing) Total purchase price Number of shares issued for acquisitions Cash consideration Contingent consideration Revaluation expense Related Party Transaction [Table] Related Party Transaction [Line Items] Equity method investment Investment Lease payment Restructuring Cost [Table] Restructuring Cost and Reserve [Line Items] Cash consideration paid Less: Value of Consent Assets (subject to Canadian Consents) held in escrow Add: Assumed liabilities related to Designated Contracts (excluding Canadian Contracts) Total Fair Value of Acquired IPR&D Assets Escrow deposit Held in escrow Reimbursement allowance Expect to pay assumed liability Escrow amount Federal State Nondeductible expenses Tax rate change Provision to return adjustments and other Change in valuation allowance Effective tax rate Deferred tax assets: Net operating loss carryforwards Research and development expenses Stock-based compensation Depreciation and amortization Operating lease liabilities Contribution Carryovers Contingent consideration Total deferred tax assets Valuation allowance Net deferred tax assets Deferred tax liabilities: Right-of-use assets IPR&D Net deferred tax liabilities Deferred tax assets (liabilities)  Effective Income Tax Rate Reconciliation [Table] Effective Income Tax Rate Reconciliation [Line Items] Provision for income taxes [custom:DeferredTaxAssets-0] [custom:ValuationAllowancePercentage-0] Deferred Tax Assets, Valuation Allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Gross operating loss carry forwards Percentage of taxable income Subsequent Event [Table] Subsequent Event [Line Items] Number of warrants Purchase of shares Proceeds from warrant exercised Number of shares stock options exercised Offering common stock issuances, shares Exercise price per share Proceeds from stock option exercised Sale of common stock Common stock , par value Proceds from private placement , gross Share price Proceds from private placement No insider trading flag. Research and development Contingent consideration. Temporary Equity [Member] Value of warrants exercised. Shares of warrants exercised. Stock issued during period value permanent equity conversion. Temporary equity shares mezzanine equity conversion. Temporary equity value mezzanine equity conversion Stock issued during period shares permanent equity conversion. Acquisition paid in equity. Increase decrease fair value of contingent liability Increase decrease in contingent liability. Payments for research and development expense Payment of deferred offering costs. Inception of Right of use asset lease liability. Consultation services. Working capital. Prepaid Expenses [Policy Text Block] Warrant Instruments [Policy Text Block] Cash held at financia institution. Consulting Service [Member] Nonrefundable down payment. Stock Options [Member] Series B Round [Member] July 2024 Firm Commitment Public Offering [Member] Issuance of common stock. Purchase of common stock. July 2024 Follow On Overallotment Warrants [Member] July 2024 Follow on Overallotment Warrant [Member] Lead Managing Underwriter [Member] October 2024 Follow On Offering [Member] Warrants exercised. October 2024 Follow On Over Allotment Option [Member] Securities Purchase Agreement [Member] Cash fee percentage. Non accountable expense allowance percentage. May 2025 Private Placement [Member] May 2025 Placement Agency Agreement [Member] Two Consultants [Member] 2025 Equity Incentive Plan [Member] 2023 Stock Option Plan [Member] Common Stock One [Member] Common Stock Two [Member] Asset Acquisition Disclosure [Text Block] ALIP Technology [Member] Dr Maidana [Member] Asset acquisition consideration transferred contingent consideration shares. Revaluation expense. LIS Technologies Inc [Member] Sharebased compensation arrangement by sharebased payment options granted weighted average remaining contractual term one. Aggregate intrinsic value, options granted. Share based compensation arrangement by share based payment award options forfeited in period total intrinsic value. Usnc Asset Acquisition [Text Block] Weighted average exercise price per share, outstanding. Weighted average exercise price per share, warrants issued. Weighted average exercise price per share, warrants exercised. Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average remaining contractual terms granted. 2025 Equity Plan [Member] Additions – land. Additions – building. Property plant and equipment additions on leasehold improvements. Property plant and equipment additions on construction in progress. Depreciation of leasehold improvements Right Of Use Asset And Lease Liabilities Disclosure [Text Block] Schedule Of Right Of Use Asset And Lease Liabilities [Table Text Block] Right Of Use Asset Roll Forward [Abstract] Right of use of asset additions. Accumulated depreciation. Schedule Of Balance Sheet Information [Table Text Block] Schedule Of Other Information Related To Leases [Table Text Block] Reimbursement allowance. Lessee operating lease liability payments due after year four. Canadian Consents [Member] Value of canadian assets held in escrow. Assumed liabilities related to designated contracts. Tax rate change, percentage. Depreciation and amortization. Operating lease liabilities. Contingent consideration. Deferred tax assets contribution carryovers. ROU asset. Deferred tax liabilities IP research and development. Deferred tax assets. Valuation allowance percentage. Percentage of taxable income. Underwriter Warrants [Member] Nuclear Technology Headquaters [Member] KRONOSMMR Microreactor Energy System [Member] Share based compensation arrangement by share based payment award options exercisable weighted average remaining contractual term. Proceeds from issuance of private placement gross. One Third Grant Date Anniversary [Member] Six Month Grant Date Anniversary [Member] Share based compensation arrangement by share based payment award options vested percentage. Grant Date Anniversary [Member] Schedule Of Property Plant And Equipments Estimated Useful Lives [Table Text Block] Warrant One [Member] Warrant Two [Member] Useful Life, Lease Term [Member] Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Expenses Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Shares, Outstanding Temporary Equity, Shares Outstanding StockIssuedDuringPeriodSharesPermanentEquityConversion Share-Based Payment Arrangement, Noncash Expense Increase (Decrease) in Prepaid Expense Increase (Decrease) in Deposit Assets Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Due to Related Parties Cash Provided by (Used in) Operating Activity, Including Discontinued Operation PaymentsForResearchAndDevelopmentExpense Payments to Acquire Investments Payments to Acquire Property, Plant, and Equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation PaymentOfDeferredOfferingCosts Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Depreciation, Depletion, and Amortization [Policy Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Class of Warrant or Right, Exercise Price of Warrants or Rights Property, Plant and Equipment, Gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment DepreciationOfLeaseholdImprovements Right Of Use Asset Roll Forward [Abstract] Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Operating Lease, Liability Asset Acquisition, Contingent Consideration, Liability Business Combination, Recognized Asset Acquired, Asset Effective Income Tax Rate Reconciliation, Percent DeferredTaxAssetsContingentConsideration Deferred Tax Assets, Gross Deferred Tax Assets, Net of Valuation Allowance DeferredTaxLiabilitiesRightsOfUseAsset DeferredTaxLiabilitiesIPResearchAndDevelopment Deferred Tax Liabilities, Net Deferred Tax Assets, Net